NCT07103512 Scalene Hold Relax Technique With Conventional Physical Therapy in Asthma
| NCT ID | NCT07103512 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2025-08-21 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2025-08-21 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the additional effects of scalene hold relax technique with conventional exercises on pulmonary function in asthma patients
Eligibility Criteria
Inclusion Criteria: * Patient diagnosed with Allergic asthma * Both male and female will be included * Age between 20 to 44 years. Exclusion Criteria: * Patient who do not provide consent * Patient with any comorbid condition such as cardiovascular disease diabetes or other chronic illness * Patient with any psychological condition that may interfere with participation or adherence to the study protocol
Contact & Investigator
Muhammad Iqbal Tariq, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07103512 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 44 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07103512 currently recruiting?
Yes, NCT07103512 is actively recruiting participants. Contact the research team at iqbal.tariq@riphah.edu.pk for enrollment information.
Where is the NCT07103512 trial being conducted?
This trial is being conducted at Mānsehra, Pakistan.
Who is sponsoring the NCT07103512 clinical trial?
NCT07103512 is sponsored by Riphah International University. The principal investigator is Muhammad Iqbal Tariq, PhD* at Riphah International University. The trial plans to enroll 26 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.